Antigen-specific TCR-T cells for acute myeloid leukemia: state of the art and challenges
S Kang, Y Li, J Qiao, X Meng, Z He, X Gao… - Frontiers in …, 2022 - frontiersin.org
The cytogenetic abnormalities and molecular mutations involved in acute myeloid leukemia
(AML) lead to unique treatment challenges. Although adoptive T-cell therapies (ACT) such …
(AML) lead to unique treatment challenges. Although adoptive T-cell therapies (ACT) such …